Acurx Pharmaceuticals, Inc. (ACXP)
Total Valuation
ACXP has a market cap or net worth of $52.73 million. The enterprise value is $45.68 million.
| Market Cap | 52.73M |
| Enterprise Value | 45.68M |
Important Dates
The last earnings date was Tuesday, November 14, 2023, before market open.
| Earnings Date | Nov 14, 2023 |
| Ex-Dividend Date | n/a |
Share Statistics
ACXP has 13.77 million shares outstanding. The number of shares has increased by 16.65% in one year.
| Shares Outstanding | 13.77M |
| Shares Change (YoY) | +16.65% |
| Shares Change (QoQ) | +6.72% |
| Owned by Insiders (%) | 17.83% |
| Owned by Institutions (%) | 6.39% |
| Float | 11.31M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 13.40 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.22, with zero debt.
| Current Ratio | 2.22 |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -223.40% and return on invested capital (ROIC) is -323.37%.
| Return on Equity (ROE) | -223.40% |
| Return on Assets (ROA) | -153.50% |
| Return on Capital (ROIC) | -323.37% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$3.18M |
| Employee Count | 4 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -3.28% in the last 52 weeks. The beta is -1.87, so ACXP's price volatility has been lower than the market average.
| Beta (1Y) | -1.87 |
| 52-Week Price Change | -3.28% |
| 50-Day Moving Average | 3.92 |
| 200-Day Moving Average | 2.92 |
| Relative Strength Index (RSI) | 52.82 |
| Average Volume (30 Days) | 859,709 |
Short Selling Information
The latest short interest is 439,051, so 3.19% of the outstanding shares have been sold short.
| Short Interest | 439,051 |
| Short Previous Month | 555,759 |
| Short % of Shares Out | 3.19% |
| Short % of Float | 3.88% |
| Short Ratio (days to cover) | 1.57 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -12.72M |
| Pretax Income | -12.72M |
| Net Income | -12.72M |
| EBITDA | -12.72M |
| EBIT | -12.72M |
| Earnings Per Share (EPS) | -$1.05 |
Balance Sheet
The company has $7.05 million in cash and no debt, giving a net cash position of $7.05 million or $0.51 per share.
| Cash & Cash Equivalents | 7.05M |
| Total Debt | n/a |
| Net Cash | 7.05M |
| Net Cash Per Share | $0.51 |
| Equity / Book Value | 3.93M |
| Book Value Per Share | 0.29 |
| Working Capital | 3.93M |
Cash Flow
| Operating Cash Flow | -7.10M |
| Capital Expenditures | n/a |
| Free Cash Flow | -7.10M |
| FCF Per Share | -$0.55 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ACXP does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Earnings Yield | -24.13% |
| FCF Yield | -13.46% |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -16.65% |
| Shareholder Yield | -16.65% |
Analyst Forecast
The average price target for ACXP is $14.00, which is 265.54% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $14.00 |
| Price Target Difference | 265.54% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |